CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Large Decline in Short Interest

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 12,800 shares, a decline of 49.8% from the January 15th total of 25,500 shares. Based on an average trading volume of 177,200 shares, the short-interest ratio is presently 0.1 days.

CERo Therapeutics Price Performance

CEROW traded down $0.00 on Thursday, reaching $0.01. The company had a trading volume of 2,661 shares, compared to its average volume of 150,756. CERo Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.25. The stock has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.01.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.